Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Top Cited Papers
- 30 November 2010
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 117 (11), 2146-2151
- https://doi.org/10.1016/j.ophtha.2010.08.016
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal InsertOphthalmology, 2010
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2010
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) StudyOphthalmology, 2009
- Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2006
- Inhibition of protein kinase C decreases prostaglandin‐induced breakdown of the blood‐retinal barrierJournal of Cellular Physiology, 2003
- Intravitreal Sustained Release of VEGF Causes Retinal Neovascularization in Rabbits and Breakdown of the Blood– Retinal Barrier in Rabbits and PrimatesExperimental Eye Research, 1997
- Progression of Retinopathy with Intensive versus Conventional Treatment in the Diabetes Control and Complications TrialOphthalmology, 1995
- Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.Proceedings of the National Academy of Sciences of the United States of America, 1995
- The Wisconsin Epidemiologic Study of Diabetic RetinopathyAmerican Journal of Ophthalmology, 1984
- Midperipheral Fundus Involvement in Diabetic RetinopathyOphthalmology, 1981